Mutual of America Capital Management LLC Has $4.21 Million Stock Holdings in Neogen Co. (NASDAQ:NEOG)

Mutual of America Capital Management LLC cut its holdings in Neogen Co. (NASDAQ:NEOG) by 4.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 269,089 shares of the company’s stock after selling 11,307 shares during the quarter. Mutual of America Capital Management LLC owned about 0.12% of Neogen worth $4,206,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in NEOG. Janney Montgomery Scott LLC lifted its stake in Neogen by 5.3% in the fourth quarter. Janney Montgomery Scott LLC now owns 82,141 shares of the company’s stock valued at $1,652,000 after acquiring an additional 4,126 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of Neogen by 5.9% in the fourth quarter. Wells Fargo & Company MN now owns 745,620 shares of the company’s stock valued at $14,994,000 after purchasing an additional 41,826 shares during the period. Corient Private Wealth LLC raised its position in shares of Neogen by 49.3% in the fourth quarter. Corient Private Wealth LLC now owns 97,987 shares of the company’s stock valued at $1,971,000 after purchasing an additional 32,339 shares during the period. Neuberger Berman Group LLC raised its position in shares of Neogen by 27.3% in the fourth quarter. Neuberger Berman Group LLC now owns 298,877 shares of the company’s stock valued at $6,010,000 after purchasing an additional 64,171 shares during the period. Finally, United Services Automobile Association raised its position in shares of Neogen by 12.5% in the fourth quarter. United Services Automobile Association now owns 16,596 shares of the company’s stock valued at $334,000 after purchasing an additional 1,849 shares during the period. 96.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

NEOG has been the topic of a number of recent analyst reports. Piper Sandler lifted their price target on shares of Neogen from $17.00 to $17.50 and gave the company a “neutral” rating in a research report on Tuesday, August 6th. StockNews.com raised shares of Neogen to a “sell” rating in a research report on Friday, September 13th.

Neogen Trading Down 0.4 %

Shares of NEOG stock opened at $17.46 on Monday. Neogen Co. has a 1 year low of $11.46 and a 1 year high of $20.89. The firm’s fifty day simple moving average is $16.63 and its 200 day simple moving average is $15.18. The firm has a market capitalization of $3.78 billion, a P/E ratio of 1,746.00 and a beta of 1.21. The company has a current ratio of 3.82, a quick ratio of 2.59 and a debt-to-equity ratio of 0.28.

Neogen (NASDAQ:NEOG) last announced its earnings results on Tuesday, July 30th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). Neogen had a positive return on equity of 3.09% and a negative net margin of 1.02%. The company had revenue of $236.80 million for the quarter, compared to the consensus estimate of $225.83 million. During the same period last year, the firm posted $0.14 EPS. The company’s revenue was down 2.1% compared to the same quarter last year. As a group, sell-side analysts predict that Neogen Co. will post 0.54 EPS for the current year.

Insider Buying and Selling

In other Neogen news, Director James P. Tobin purchased 3,000 shares of the stock in a transaction on Tuesday, August 6th. The shares were purchased at an average price of $16.86 per share, with a total value of $50,580.00. Following the acquisition, the director now directly owns 23,392 shares of the company’s stock, valued at approximately $394,389.12. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.71% of the stock is currently owned by insiders.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.